Jinling Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Jinling Pharmaceutical has a total shareholder equity of CN¥4.4B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥5.4B and CN¥918.3M respectively. Jinling Pharmaceutical's EBIT is CN¥31.3M making its interest coverage ratio -1.3. It has cash and short-term investments of CN¥2.1B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -1.3x |
| Cash | CN¥2.11b |
| Equity | CN¥4.44b |
| Total liabilities | CN¥918.35m |
| Total assets | CN¥5.36b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 000919's short term assets (CN¥3.1B) exceed its short term liabilities (CN¥896.6M).
Long Term Liabilities: 000919's short term assets (CN¥3.1B) exceed its long term liabilities (CN¥21.7M).
Debt to Equity History and Analysis
Debt Level: 000919 is debt free.
Reducing Debt: 000919 had no debt 5 years ago.
Debt Coverage: 000919 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 000919 has no debt, therefore coverage of interest payments is not a concern.